DK123071B - Fremgangsmåde til fremstilling af medicinaltabletter med reguleret frigivelse. - Google Patents

Fremgangsmåde til fremstilling af medicinaltabletter med reguleret frigivelse.

Info

Publication number
DK123071B
DK123071B DK153068AA DK153068A DK123071B DK 123071 B DK123071 B DK 123071B DK 153068A A DK153068A A DK 153068AA DK 153068 A DK153068 A DK 153068A DK 123071 B DK123071 B DK 123071B
Authority
DK
Denmark
Prior art keywords
preparation
controlled release
medicinal tablets
release medicinal
tablets
Prior art date
Application number
DK153068AA
Other languages
English (en)
Inventor
J Hill
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK123071B publication Critical patent/DK123071B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK153068AA 1967-04-07 1968-04-05 Fremgangsmåde til fremstilling af medicinaltabletter med reguleret frigivelse. DK123071B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62906667A 1967-04-07 1967-04-07

Publications (1)

Publication Number Publication Date
DK123071B true DK123071B (da) 1972-05-15

Family

ID=24521437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK153068AA DK123071B (da) 1967-04-07 1968-04-05 Fremgangsmåde til fremstilling af medicinaltabletter med reguleret frigivelse.

Country Status (7)

Country Link
US (1) US3458622A (da)
DE (1) DE1767170A1 (da)
DK (1) DK123071B (da)
FR (2) FR1588801A (da)
GB (1) GB1235543A (da)
NL (1) NL6804772A (da)
SE (1) SE353019B (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA765931B (en) * 1975-10-10 1977-09-28 Squibb & Sons Inc Controlled release tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4309404A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248857A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
DE3448522C2 (de) * 1983-11-11 1995-08-24 Egyt Gyogyszervegyeszeti Gyar Pharmazeutische Präparate, insbesondere Tabletten, mit geregelter beziehungsweise verzögerter Wirkstoffabgabe, sowie Verfahren zur Herstellung derselben
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3535536A1 (de) * 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4738850A (en) * 1986-05-27 1988-04-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
RO112991B1 (ro) * 1992-09-18 1998-03-30 Yamanouchi Pharma Co Ltd Preparat tip hidrogel, cu eliberare sustinuta
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
ES2194863T3 (es) * 1992-11-30 2003-12-01 Kv Pharm Co Materiales farmaceuticos con enmascarado de sabor.
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5840338A (en) * 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
US8226598B2 (en) * 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
EP1347748A2 (en) 2000-12-05 2003-10-01 MacGregor, Alexander Hydrostatic delivery system for controlled delivery of agent
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
PL1789021T3 (pl) * 2004-08-13 2012-04-30 Boehringer Ingelheim Int Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól
CA2576386A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US20080318311A1 (en) 2004-11-02 2008-12-25 Gangagen Life Sciences Inc. Encapsulated Bacteriophage Formulation
KR100753480B1 (ko) * 2006-01-27 2007-08-31 씨제이 주식회사 잘토프로펜 함유 서방성 정제 및 그 제조방법
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
EP2063862A2 (en) * 2006-09-04 2009-06-03 Matrix Laboratories Ltd Pharmaceutical formulation for use in hiv therapy
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
NL265428A (da) * 1960-06-06
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
US3346449A (en) * 1963-09-27 1967-10-10 Hoffmann La Roche d-methorphan compositions and methods of making same
US3330729A (en) * 1963-10-04 1967-07-11 Goodrich Co B F Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent

Also Published As

Publication number Publication date
FR1588801A (da) 1970-03-16
SE353019B (da) 1973-01-22
FR8060M (da) 1970-07-06
GB1235543A (en) 1971-06-16
NL6804772A (da) 1968-10-08
DE1767170A1 (de) 1971-08-12
US3458622A (en) 1969-07-29

Similar Documents

Publication Publication Date Title
DK123071B (da) Fremgangsmåde til fremstilling af medicinaltabletter med reguleret frigivelse.
DK132303B (da) Fremgangsmåde til fremstilling af en lægemiddelform med retarderende virkning.
DK122222B (da) Fremgangsmåde til fremstilling af alk-3-en-1-oler.
DK133783B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxy-1-thio-alfa-D-galacto-octopyranosider.
DK124080B (da) Fremgangsmåde til fremstilling af D-6-metyl-8-cyanmetylergolin.
DK127853B (da) Analogifremgangsmåde til fremstilling af benzodipyroner.
DK121454B (da) Fremgangsmåde til fremstilling af en hjælpestofholdig vaccine.
DK118820B (da) Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner.
DK118081B (da) Fremgangsmåde til fremstilling af isoksazolderivater.
DK131936C (da) Analogifremgangsmade til fremstilling af 5-phenyl-1h-1,5-benzodiazepin-2,4-dioner
DK119307B (da) Fremgangsmåde til fremstilling af ketonitriler.
DK134911B (da) Fremgangsmåde til fremstilling af 3-formylrifamycin SV-derivater.
DK119724B (da) Fremgangsmåde til fremstilling af en antigenfri vaccine.
DK123868B (da) Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater.
DK122758B (da) Fremgangsmåde til fremstilling af α-methyl-multicyclo-methylaminer.
DK121922B (da) Fremgangsmåde til fremstilling af formede tabletter.
DK122708B (da) Fremgangsmåde til fremstilling af farmaceutiske tabletter med langvarig virkning.
DK118507B (da) Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater.
DK122522B (da) Fremgangsmåde til fremstilling af dichlorquinoliner.
DK123100B (da) Fremgangsmåde til fremstilling af N-tritylimidazoler.
DK132447C (da) Fremgangsmade til fremstilling af kalvediarrevirusvaccine
DK119939B (da) Fremgangsmåde til fremstilling af tetanus-vaccine.
DK123291B (da) Fremgangsmåde til fremstilling af methylisobutylketon.
DK147695C (da) Fremgangsmaade til fremstilling af hoejt doserede tabletter af tetracyclin-derivater
DK119976B (da) Analogifremgangsmåde til fremstilling af 18-methyl-19-nor-17α-hydroxyprogesteroner og -17-estere deraf.

Legal Events

Date Code Title Description
PUP Patent expired